IL114270A0 - O-glycosylated authentic igf-i and truncated variants thereof a method of preparation thereof and pharmaceutical compositions - Google Patents

O-glycosylated authentic igf-i and truncated variants thereof a method of preparation thereof and pharmaceutical compositions

Info

Publication number
IL114270A0
IL114270A0 IL11427095A IL11427095A IL114270A0 IL 114270 A0 IL114270 A0 IL 114270A0 IL 11427095 A IL11427095 A IL 11427095A IL 11427095 A IL11427095 A IL 11427095A IL 114270 A0 IL114270 A0 IL 114270A0
Authority
IL
Israel
Prior art keywords
glycosylated
preparation
pharmaceutical compositions
truncated variants
authentic igf
Prior art date
Application number
IL11427095A
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of IL114270A0 publication Critical patent/IL114270A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL11427095A 1994-07-01 1995-06-22 O-glycosylated authentic igf-i and truncated variants thereof a method of preparation thereof and pharmaceutical compositions IL114270A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402332A SE9402332D0 (en) 1994-07-01 1994-07-01 IGF-1

Publications (1)

Publication Number Publication Date
IL114270A0 true IL114270A0 (en) 1995-10-31

Family

ID=20394599

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11427095A IL114270A0 (en) 1994-07-01 1995-06-22 O-glycosylated authentic igf-i and truncated variants thereof a method of preparation thereof and pharmaceutical compositions

Country Status (7)

Country Link
EP (1) EP0769022A1 (en)
JP (1) JPH10502623A (en)
AU (1) AU2940695A (en)
CA (1) CA2193399A1 (en)
IL (1) IL114270A0 (en)
SE (1) SE9402332D0 (en)
WO (1) WO1996001275A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501472D0 (en) * 1995-04-21 1995-04-21 Pharmacia Ab Truncated IGF-I
SE9802938D0 (en) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
ES2541810T3 (en) 2005-01-07 2015-07-24 Regeneron Pharmaceuticals, Inc. IGF-1 fusion polypeptides and therapeutic uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819826D0 (en) * 1988-08-20 1988-09-21 Kabivitrum Ab Glycosylated igf-1
ATE151293T1 (en) * 1991-08-01 1997-04-15 Genentech Inc IGF-I TO IMPROVE THE NEURAL SITUATION

Also Published As

Publication number Publication date
EP0769022A1 (en) 1997-04-23
CA2193399A1 (en) 1996-01-18
AU2940695A (en) 1996-01-25
SE9402332D0 (en) 1994-07-01
JPH10502623A (en) 1998-03-10
WO1996001275A1 (en) 1996-01-18

Similar Documents

Publication Publication Date Title
ZA944773B (en) Sustained release compositions and a method of preparing pharmaceutical compositions and a method of preparing pharmaceutical compositions
ZA968907B (en) Compositions and methods for buccal delivery of pharmaceutical agents
ZA942804B (en) Oral drug delivery compositions and methods
IL113456A0 (en) Modified amino acids for oral drug delivery
HUP0003761A2 (en) Substituted alkanohydroxamic acids and pharmaceutical compositions containing them
IL191904A0 (en) Pharmaceutical and compositions containing a?? fragments
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
GB9710800D0 (en) Pharmaceutical composition and method of preparing it
IL106578A0 (en) A method and pharmaceutical compositions for drug targeting
GB9324045D0 (en) Sustained release compositions and a method of preparing pharmaceutical compositions
IL114736A0 (en) Peptides theit production and pharmaceutical compositions containing them
IL116480A0 (en) Acetic acid deriratives their preparation and pharmaceutical compositions containing them
AP9600784A0 (en) Oxathiolanes method for their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL114270A0 (en) O-glycosylated authentic igf-i and truncated variants thereof a method of preparation thereof and pharmaceutical compositions
IL117629A0 (en) Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof
HUP9701293A3 (en) New salts without unsavoury taste and pharmaceutical compositions containing them
HUP9701618A3 (en) Pharmaceutical composition containing tramadol and a calcium-canal-antagonist
IL116742A0 (en) Pharmaceutical composition comprising a growth hormone
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
IL122519A0 (en) Stabilized pharmaceutical compositions comprising a growth hormone and a peptide
GB2282966B (en) A pharmaceutical composition having anti-decrepit action and a process for preparation thereof
IL116741A0 (en) Pharmaceutical composition comprising a growth hormone